$56.48 +0.09 (%) Merck & Co Inc - New York Stock Exchange, Inc.

May. 27, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Price Data, Earnings Boost Stock Futures; Priceline, Fossil Lead

    IBD | Feb. 17, 2016 | 09:09AM EST
  2. Intercept Pharma Spikes On Report That It’s Exploring A Sale

    IBD | Feb. 12, 2016 | 15:30PM EST
  3. Incyte Plummets After Stopping Trial Of Jakafi In Pancreatic Cancer

    IBD | Feb. 11, 2016 | 11:16AM EST
  4. ALK Announces Merck Submits BLA to FDA for Investigational House Dust Mite SLIT-tablet

    Benzinga | Feb. 10, 2016 | 04:15AM EST
  5. Stocks To Buy For A Recession — And For A Recovery

    IBD | Feb. 9, 2016 | 13:46PM EST
  6. Stocks Open Down, Reverse Higher; Prestige, Nike, Fastenal Soar

    IBD | Feb. 4, 2016 | 10:50AM EST
  7. Merck & Co., Inc. Falters After Q4 Report

    Benzinga | Feb. 3, 2016 | 14:00PM EST
  8. Merck Stock Slides As Q4 Revenue, Guidance Miss Expectations

    IBD | Feb. 3, 2016 | 11:44AM EST
  9. Stocks Backtrack On Services Data; Seagate, Edwards, WebMD Jump

    IBD | Feb. 3, 2016 | 10:48AM EST
  10. Stock Futures Up As Oil Behaves; Syngenta Up On ChemChina Deal

    IBD | Feb. 3, 2016 | 09:03AM EST
  11. Polcari: Stocks Slide, KS Fed Pres Ester George Suggests Rate Hike

    IBD | Feb. 3, 2016 | 09:01AM EST
  12. Keep an Eye on These 10 Stocks for February 3, 2016

    Benzinga | Feb. 3, 2016 | 04:28AM EST
  13. Earnings: Pharma Tends to Top Street Estimate—Can PFE, MRK Repeat?

    Benzinga | Feb. 1, 2016 | 10:38AM EST
  14. Stock Marquee is Crowded in Week Ahead: Oil, Earnings, Labor Data

    Benzinga | Feb. 1, 2016 | 10:28AM EST
  15. Merck Receives FDA Approval of Hep C Drug ZEPATIER; To Cost $54,600/Patient for 12-Week Course

    Benzinga | Jan. 28, 2016 | 19:11PM EST
  16. Affimed to Collaborate with Merck to Evaluate AFM13 in Combination with KEYTRUDA for Patients with Hodgkin Lymphoma

    Benzinga | Jan. 25, 2016 | 05:02AM EST
  17. Merck

    IBD | Jan. 15, 2016 | 18:43PM EST
  18. Merck, BioLineRx teaming up

    IBD | Jan. 12, 2016 | 18:40PM EST
  19. Fast Money Traders Share Their Biotech Picks

    Benzinga | Jan. 12, 2016 | 07:14AM EST
  20. Richard Snow Makes Huge Increases in Big-Name Stocks

    GuruFocus | Jan. 8, 2016 | 14:57PM EST
  21. A Calmer Year For Pharma?

    IBD | Jan. 6, 2016 | 18:47PM EST
  22. 3 Potential Blockbuster Drugs Launching in 2016

    IBD | Jan. 6, 2016 | 09:42AM EST
  23. Washington University Initiates Clinical Study of Verastem's VS-6063 in Combination with Merck's Pembrolizumab and Gemcitabine in Pancreatic Cancer

    Benzinga | Jan. 6, 2016 | 07:53AM EST
  24. Lilly Guidance Misses Estimates On Lower Sales

    IBD | Jan. 5, 2016 | 13:18PM EST
  25. Baxalta Cuts Cancer Deal As Shire Circles Nearer

    IBD | Jan. 4, 2016 | 12:52PM EST
  26. The 5 Top-Performing Big-Cap Drug Stocks Of 2015

    IBD | Dec. 30, 2015 | 14:16PM EST
  27. 5 Top Stocks of the Outperforming Vanguard Health Care Fund

    GuruFocus | Dec. 24, 2015 | 15:44PM EST
  28. 5 Guru Picks in Volatile Biotech Industry

    GuruFocus | Dec. 23, 2015 | 14:24PM EST
  29. Kahn Brothers' Largest Sales During 3rd Quarter

    GuruFocus | Dec. 22, 2015 | 16:13PM EST
  30. ALK Sells European Veterinary Business to Fidelio Capital; Terms Not Disclosed

    Benzinga | Dec. 21, 2015 | 04:13AM EST
  31. Merck's KEYTRUDA Significantly Improves Survival Compared to Chemotherapy in Previously-Treated Patients with Non-Small Cell Lung Cancer Whose Tumors Express Any Level of PD-L1

    Benzinga | Dec. 19, 2015 | 11:52AM EST
  32. 4 Top Dividend Plays To Help Cure Stock Price Blues

    IBD | Dec. 17, 2015 | 17:14PM EST
  33. Biothera Announces Clinical Study to Evaluate Combination Therapy of Imprime PGG

    Benzinga | Dec. 10, 2015 | 09:00AM EST
  34. Apple, Intel, Viacom, IBM Among Best Value Stocks

    IBD | Dec. 9, 2015 | 14:27PM EST
  35. Oil Slips, Drags On Stock Futures; Keurig Soars, Chipotle Crumbles

    IBD | Dec. 7, 2015 | 09:09AM EST
  36. Must Watch Stocks for Today

    Benzinga | Dec. 7, 2015 | 04:25AM EST
  37. Benzinga's Weekend M&A Chatter

    Benzinga | Dec. 6, 2015 | 20:45PM EST
  38. Amgen, Merck target cancer

    IBD | Dec. 4, 2015 | 18:37PM EST
  39. Relypsa Stock Jumps On Buyout Rumors

    IBD | Dec. 4, 2015 | 15:31PM EST
  40. Amgen Expands Work With Merck, Files Biosimilar In EU

    IBD | Dec. 4, 2015 | 13:46PM EST
  41. Stocks Wobble After ECB Rate Vote; Avago, Dyax up

    IBD | Dec. 3, 2015 | 11:40AM EST
  42. Merck

    IBD | Dec. 1, 2015 | 18:47PM EST
  43. 3 Big Pharma Upgrades (And One Downgrade) At Barclays

    IBD | Dec. 1, 2015 | 15:31PM EST
  44. Stocks Hold Solid Gains; Boeing Leads Dow; LinkedIn Revs Up

    IBD | Dec. 1, 2015 | 11:58AM EST
  45. Stocks, Volume Open Higher; Early Risers: Boeing, Thor, Wynn

    IBD | Dec. 1, 2015 | 10:34AM EST
  46. Amazon's PT Raised; Yum, J&J, Merck, Lilly Upgraded

    IBD | Dec. 1, 2015 | 09:15AM EST
  47. Small Caps Show Early Strength; Microsoft, Merck, Fitbit Rising

    IBD | Nov. 30, 2015 | 09:09AM EST
  48. Deere Announces Factory Workforce Adjustments, 220 Employees On Indefinite Leave Starting Feb 2016

    Benzinga | Nov. 30, 2015 | 09:01AM EST
  49. MITICURE for house Dust Mite Allergic Rhinitis Now Available in Japan

    Benzinga | Nov. 25, 2015 | 20:42PM EST
  50. Biotechs Weaken, But These Names Have Bullish Charts

    IBD | Nov. 25, 2015 | 17:19PM EST
Trading Center